Clinicians have identified new continuous glucose monitoring (CGM) targets for patients post-total pancreatectomy with islet autotransplantation (TPIAT). Involving 256 CGM and hemoglobin A1c (HbA1c) pairings from 82 patients, the study suggests a time in range (TIR) of 70-140 mg/dl at 50% and TIR of 70-180 mg/dl at 75% as minimum benchmarks. These targets aim to optimize diabetes management and mitigate metabolic stress on transplanted islets, prompting necessary insulin adjustments when unmet.
Journal Article by Somani Z, Hodges JS (…) Bellin MD et 4 al. in Clin Transplant
© 2025 The Author(s). Clinical Transplantation published by Wiley Periodicals LLC.